Red X iconGreen tick iconYellow tick icon

2009

Mackenzie KA, Simcock JW, Lainchbury JG, Currie MJ, Lynn KL. Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient. Transplant Proc. 2009;41(10):4414-5.

Chin PK, Beckert LE, Gunningham S, Edwards AL, Robinson BA. Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients. Intern Med J. 2009;39(12):819-25.

Dachs GU, Hunt MA, Syddall S, Singleton DC, Patterson AV. Bystander or no bystander for gene directed enzyme prodrug therapy. Molecules. 2009;14(11):4517-45.

2008

Dachs GU, Currie MJ, McKenzie F, Jeffreys M, Cox B, Foliaki S, Le Marchand L, Robinson BA. Cancer disparities in indigenous Polynesian populations: Maori, Native Hawaiians and Pacific people. Lancet Oncology, 2008 May; 9: 473-484.

Hunt MA, Dachs GU, Currie MJ. 2008 Vascular targeted gene therapy in cancer treatment. In 'New Gene Therapy and Cancer Research', (Chapter IV, pp. 145-182), Ed. WB Gustafsson. Nova Science Publishers Inc., (New York). ISBN: 1-60021-969-1.

2007

Gunningham SP, Currie MJ, Morrin HR, Tan EY, Turley H, Dachs GU, Watson AI, Frampton C, Robinson BA, Fox SB. The angiogenic factor Thymidine Phosphorylase upregulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers. J Pathol. 2007 Jul;212(3):335-44.

Vissers M, Gunningham SP, Morrison MJ, Dachs GU, Currie MJ. Modulation of hypoxia-inducible factor-1 alpha in cultured primary cells by intracellular ascorbate. Free Radic Biol Med 2007; 42: 765-772.

2006

Dachs GU, Steele AJ, Coralli C, Kanthou C, Brooks AC, Gunningham SP, Currie MJ, Watson AI, Robinson BA, Tozer GM. Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression. BMC Cancer 2006; 6: 280.

Jarvis MD, Rademaker MT, Ellmers LJ, Currie MJ, McKenzie JL, Palmer BR, Frampton CM, Richards AM, Cameron VA. Comparison of infarct-derived and control ovine cardiac myofibroblasts in culture: response to cytokines and natriuretic peptide receptor expression profiles. Am J Physiol: Heart Circ Physiol 2006; 291:1952-1958.

2005

Morrin H, The Christchurch tissue bank to support cancer research. The New Zealand Medical Journal 2005: 118(1225): 1-12.

Currie MJ, Hanrahan V, Gunningham SP, Morrin HR, Frampton C, Han C, Robinson BA, Fox SB. Expression of HIF-1 alpha in human tumours – Reply J.Clin.Path 2005: 58(3): 336-336.

Williams KJ, Telfer BA, Xenaki D, Sheridan MR, Desbaillets I, Peters HJ, Honess D, Harris AL, Dachs GU, Kogel A, Stratford IJ. Enhanced response to radiotherapy in tumours deficient in the function of hypoxia-inducible factor-1. Radiother Oncol. 2005: 75(1):89-98.

Dachs GU, Tupper J, Tozer GM. From bench to bedside for gene-directed enzyme prodrug therapy of cancer. Anticancer Drugs 2005: 16(4):349-59.

Back to top